Previous Close | 2.1700 |
Open | 2.1800 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 2.1800 - 2.3820 |
52 Week Range | 1.9270 - 19.2000 |
Volume | |
Avg. Volume | 266,335 |
Market Cap | 2.741M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -3.2500 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Roseland, NJ, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it will participate in the upcoming Unite 2024 Conference on September 18th - 20th in Barcelona, Spain. “We are excited to be part of Unity’s Unite 2024 conference,” said Vadim Mats, CEO of Gaxos. “As we engage with development communities, gamers, and industry leaders, we forge meaningful relationships t
Roseland, NJ, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it will participate in the upcoming Devcom Developer Conference on August 18th - Aug 20th and Gamescom Conference on August 21st – 25th in Cologne, Germany. “We are excited to be part of Devcom and Gamescom this year,” said Vadim Mats, CEO of Gaxos. “These conferences provide us with a fantastic opportunit
Significant Milestone as Company Transitions from Development to Revenue Generation. Roseland, NJ, July 30, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced the commercial launch of Gaxos Health and recorded its initial revenue this week. “We are thrilled to announce the commercial launch of Gaxos Health,” said Vadim Mats, CEO of Gaxos. “With the rising demand for personalized heal